Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,301–3,325 of 7,816 matching trials · page 133 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Home-based Brain Stimulation for Memory NCT04783350 Transcranial alternating current stimulation (tACS) Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Hebrew SeniorLife OTHER |
2024-06-25 |
|
China Healthy Aging Cohort Study NCT06472674 No intervention Runs in: China · 1 site |
NA other |
RECRUITING | 6,780 | Xuanwu Hospital, Beijing OTHER |
2024-06-25 |
|
Evaluation of the Effectiveness of Narrative Nursing NCT06473220 Narrative nursing Runs in: China · 1 site |
NA other |
COMPLETED | 100 | Nanjing Medical University OTHER |
2024-06-25 |
|
Cerebrovascular Reactivity in Alzheimer's Disease NCT03650816 Doppler ultrasonography; Biospecimen collection Runs in: France · 1 site |
NA other |
COMPLETED | 58 | Assistance Publique - Hôpitaux de Paris OTHER |
2024-06-24 |
|
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice NCT05877391 SGM Communication Intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | University of Colorado, Denver OTHER |
2024-06-24 |
|
Brain Energy Metabolism and Sleep in Adults NCT03929302 MyTAP oral appliance plus mouth shield Runs in: United States · 1 site |
NA other |
TERMINATED | 41 | The University of Texas at Dallas OTHER |
2024-06-20 |
|
Comparison of Two Non-invasive Neuromodulation Techniques as Synergistic Therapy to Cognitive Stimulation in Amnestic Mild Cognitive Impairment (aMCI) NCT06467253 1. rTMS + CS; 2. rTMS Sham + CS; 3. tDCS + CS; 4. tDCS Sham + CS Runs in: Mexico · 1 site |
NA other |
RECRUITING | 60 | Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente OTHER |
2024-06-20 |
|
Brain Injury Outcomes (BIO) Study NCT00724607 Runs in: United States · 1 site |
NA other |
COMPLETED | 91 | VA Office of Research and Development OTHER_GOV |
2024-06-18 |
|
Progressive Muscle Relaxation Exercise on Care Burden, Depression, Anxiety, and Stress Levels in Dementia Caregivers NCT06143826 Progressive muscle relaxation exercises Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 50 | Atlas University OTHER |
2024-06-18 |
|
A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease NCT02127476 KHK6640; Matching Placebo Runs in: Belgium; Finland; Netherlands; Serbia; Sweden · 9 sites |
PHASE1 other |
COMPLETED | 57 | Kyowa Kirin Co., Ltd. INDUSTRY |
2024-06-17 |
|
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension NCT04846426 Runs in: United Kingdom · 4 sites |
NA other |
TERMINATED | 67 | Novoic Limited INDUSTRY |
2024-06-14 |
|
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension NCT04951284 Runs in: United States · 1 site |
NA other |
TERMINATED | 42 | Novoic Limited INDUSTRY |
2024-06-14 |
|
VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment. NCT05514756 Active t-VNS; Sham t-VNS; Baseline assessments Runs in: Ireland · 1 site |
NA other |
COMPLETED | 40 | Tallaght University Hospital OTHER |
2024-06-14 |
|
Dapagliflozin In Alzheimer's Disease NCT03801642 Dapagliflozin; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 46 | Jeff Burns, MD OTHER |
2024-06-13 |
|
Developing and Assessing an Innovative Exergaming Technology for Older Adults Living in Long-term Care Homes NCT05130203 MouvMat Exergaming; Standard Recreational Programming Runs in: Canada · 2 sites |
NA other |
UNKNOWN | 60 | University of Toronto OTHER |
2024-06-13 |
|
HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms NCT03805659 HD-tDCS; Sham Runs in: United States · 1 site |
NA other |
COMPLETED | 6 | Medical College of Wisconsin OTHER |
2024-06-11 |
|
Hasan Kalyoncu University NCT06453070 No intervention was made Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 103 | Hasan Kalyoncu University OTHER |
2024-06-11 |
|
Enhanced CJD Surveillance in the Older Population NCT02629640 Medical history questionnaire; Clinical assessment and review; Part... Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 30 | University of Edinburgh OTHER |
2024-06-10 |
|
Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein NCT05529277 Dementia Care Management Runs in: Germany · 6 sites |
NA other |
UNKNOWN | 93 | German Center for Neurodegenerative Diseases (DZNE) OTHER |
2024-06-10 |
|
The Use of PARO to Decrease Agitation in Persons With Dementia and/or Delirium NCT05565703 PARO Robotic Seal Intervention; Attention Control Runs in: United States · 1 site |
NA other |
COMPLETED | 104 | University of Pennsylvania OTHER |
2024-06-10 |
|
Effects of the Humanitude® Care Methodology on Health Professionals' Perception NCT06450249 Humanitude® Care Methodology (HCM) training sessions; Self-administ... Runs in: France · 2 sites |
NA other |
COMPLETED | 455 | Lille Catholic University OTHER |
2024-06-10 |
|
DHA Brain Delivery Trial NCT03613844 DHA; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 365 | University of Southern California OTHER |
2024-06-07 |
|
Nutrition Interventions for Cognitive Enhancement NCT03841539 Mediterranean Diet; Study Supplement; Low-fat Diet Runs in: United States · 1 site |
NA other |
COMPLETED | 209 | University of Kansas Medical Center OTHER |
2024-06-07 |
|
Safe Brain Initiative, Operationalizing Precision Anaesthesia NCT05765162 Patient reported ourcomes Runs in: Denmark · 1 site |
NA other |
UNKNOWN | 15,000 | University of Southern Denmark OTHER |
2024-06-07 |
|
Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis NCT06439355 Fasting blood test; Subject interview; Motor assessment; Neurocogni... Runs in: France · 1 site |
NA other |
UNKNOWN | 66 | Centre Hospitalier Universitaire Dijon OTHER |
2024-06-07 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial